Big Pharma brings home the cash, slices payroll

The Bush Administration was looking for new jobs when it announced a tax amnesty program aimed at encouraging multinationals to repatriate foreign profits. The New York Times reports that the drug industry was the most enthusiastic sector when it came to bringing the money home--to the tune of $100 billion. But instead of adding new jobs, the pharma companies have been cutting them. And now that the two-year program is over, the drug companies are once again turning to shelters to move their money into other markets. In some cases that involves designating other markets as more profitable than their U.S. market, even though the U.S. has traditionally served as pharma's global cash cow.

- read the article from The New York Times

Related Articles:
Nabi cuts jobs, explores company sale. Report
Bayer axes 6,100 jobs in wake of Schering deal. Report
Pfizer cuts 10,000 jobs. Report
Abbott eliminates hundreds of jobs in restructuring. Report
Lilly to Icos: Merry Christmas, you're fired. Report

Suggested Articles

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.

The financing, which attracted support from Roche Venture Fund, sets Palladio up to test its vasopressin V2 receptor antagonist in a kidney disease.

A new atlas of 500,000 cardiac cells could help researchers better understand how a healthy heart operates—and what goes wrong in heart disease.